In a study at University of Copenhagen and Bispebjerg Hospital ,40 COPD patients and 20 control were included in Double blind placebo controlled randomised study.
2gm per day of vitamin B3(Nicotinamide riboside) were given to one group and placebo was given to other group
After 12 weeks inflammatory marker interleukin 8,IL8 was measured in both group
The group receiving VITAMIN B3 showed 53% reduction in the level of IL8 as compared to the group which did receive placebo
After another 12 weeks this reduction was 63%
NAD which reduces with age was higher in the group receiving VITAMIN B3 .
NAD reduction is correlated with aging process and DNA methylation.With aging the level of NAD reduces in body.
This study shows that treatment with VITAMIN B3 may be beneficial in diseases of lungs where inlmmations due to infections or pollutants is responsible for lung damages and disease manifestations
REFERENCES: Published online 8.30pm,27.11.24
Dr Dev Kumar Jha
Fellowship in Pediatric Pulmonology,AIIMS,New Delhi
M.B.B.S(Gold Medalist)
M.D.(Pediatrics)
Recipient of Bharat Ratna Dr APJ Abdul Kalam Azad National Icon Award 2021 inHealth Services
Vice President-Pediatric Respiratory Society Delhi
Visiting Consultant-Yashoda Super Speciality Hospital,Nehru Nagar,Kaushambi, Yashoda Medicity,Indirapuram,Ghaziabad Delhi NCR
Head of Pediatric Pulmonology Division, Department of Pediatrics,Santosh Medical College Hospital,Ghaziabad,Delhi NCR
Director & Senior Consultant- Dr Dev CHILD HEALTH CARE & CHILD CHEST SUPER SPECIALITY CLINIC,Lajpat Nagar,Sahibabad,Delhi-NCR, Contact -01203158081,9971720128,9873446805
Coordinator & Director- DDCD-Dr Dev Classes for Doctors,Whatsapp 9899186848